Enrolling

A Study of Baricitinib (LY3009104) in Children With COVID-19 (COV-BARRIER)

I4V-MC-KHAB -

The purpose for this study is to determine if the study drug Baricitinib is effective and safe in hospitalized pediatric participants with Coronavirus disease 2019 (COVID -19) and to confirm the dose.

Enter your city or zip code to find the nearest site

See if You May Qualify

Answer a few questions to see if you meet key criteria for this study.

Trial Summary

Age Range
2 - 18 years
Conditions the trial is for
COVID-19
What the trial is testing?
Baricitinib, LY3009104
Could I receive a Placebo?
No
Enrollment Goal
24
Trial Dates
Dec 21, 2021 - Aug 2024
How long will I be in the trial?
Your participation could last about 60 days and may include up to 8 visits to the study center, as well as daily assessments.
Trial Phase
III

Key Requirements

Clinical trials have inclusion and exclusion requirements to determine which individuals qualify for participation. Listed below are key requirements for this clinical trial, but there may be additional requirements to qualify.

Participants Must:

  • Participants must be hospitalized with coronavirus (COVID-19) infection

  • Participants must need oxygen therapy

Participants Must Not:

  • Participants must not be taking biologic therapy or other drugs which suppresses the body’s immune response

  • Participants must not have active tuberculosis (TB)

  • Participants must not have any other serious infection (besides COVID-19)

  • Participants must not need a machine to help them breathe (ventilator) at study entry

  • Participants must not have Cancer

  • Participants must not have a history of a blood clot

  • Participants must not be pregnant or breastfeeding

Lilly Trial Alerts

Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.

Clinical Trial Resources

Immunology  Research

Click the below button to learn more about our autoimmune disease research and clinical trials.

Learn More

Learn About Our Pediatric Research

With the help of research study participants, we are learning about pediatric conditions and potential new approaches to treating disease.

Learn More

Clinical Trial Participation: What to Expect

A clinical trial is a scientific study. It helps us learn if a new medicine or treatment works and how it works. Clinical trials can also be called clinical research studies. Learn more about clinical research studies and what to expect when taking part in a clinical trial.